methylselenic acid has been researched along with Melanoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boucher, KM; Cassidy, JP; Cassidy, PB; Fain, HD; Florell, SR; Gerads, R; Grossman, D; Leachman, SA; Moos, PJ; Tran, SM | 1 |
Andresen, L; Hagemann-Jensen, M; Kehlet, S; Pastorekova, S; Skov, S; Uhlenbrock, F | 1 |
2 other study(ies) available for methylselenic acid and Melanoma
Article | Year |
---|---|
Selenium for the prevention of cutaneous melanoma.
Topics: Animals; Cell Cycle; Cell Line, Tumor; Cell Survival; Female; Human Growth Hormone; Humans; Male; Melanoma; Mice; Mice, Transgenic; Organoselenium Compounds; Proportional Hazards Models; RNA; Selenium; Selenocysteine; Skin Neoplasms; Sodium Selenite; Ultraviolet Rays | 2013 |
The NKG2D ligand ULBP2 is specifically regulated through an invariant chain-dependent endosomal pathway.
Topics: Antigens, Differentiation, B-Lymphocyte; Antigens, Surface; Biological Transport; Carbazoles; CD4-Positive T-Lymphocytes; Cell Line, Tumor; Depsipeptides; Endosomes; Enzyme Inhibitors; GPI-Linked Proteins; HEK293 Cells; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Intercellular Signaling Peptides and Proteins; Jurkat Cells; Lymphocyte Activation; Melanoma; Neoplasms; Organoselenium Compounds; Protein Kinase C; RNA Interference; RNA, Messenger; RNA, Small Interfering; Transcription, Genetic; Vorinostat | 2014 |